Emergency department management of acute exacerbations of chronic obstructive pulmonary disease and factors associated with hospitalization by Khialani, Bharat et al.
Bond University
Research Repository
Emergency department management of acute exacerbations of chronic obstructive pulmonary
disease and factors associated with hospitalization
Khialani, Bharat; Sivakumaran, Pathmanathan; Keijzers, Gerben; Sriram, Krishna Bajee
Published in:
Journal of Research in Medical Sciences
Published: 01/01/2014
Document Version:
Publisher's PDF, also known as Version of record
Link to publication in Bond University research repository.
Recommended citation(APA):
Khialani, B., Sivakumaran, P., Keijzers, G., & Sriram, K. B. (2014). Emergency department management of
acute exacerbations of chronic obstructive pulmonary disease and factors associated with hospitalization.
Journal of Research in Medical Sciences, 19(4), 297-303.
http://jrms.mui.ac.ir/index.php/jrms/article/view/9909/4599
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
For more information, or if you believe that this document breaches copyright, please contact the Bond University research repository
coordinator.
Download date: 11 Sep 2020
Journal of Research in Medical Sciences | April 2014 |297
Emergency department management of acute 
exacerbations of chronic obstructive pulmonary 
disease and factors associated with hospitalization
Bharat Khialani1, Pathmanathan Sivakumaran1,2, Gerben Keijzers2,3,4, Krishna Bajee Sriram1,2
1Department of Respiratory Medicine, Gold Coast University Hospital, 2School of Medicine, Parklands Drive, Griffith University, 3Department 
of Emergency Medicine, Gold Coast University Hospital, 1 Hospital Boulevard, Southport, Queensland 4215, Australia, 4School of Medicine, 
Bond University, 4 University Dr, Robina Queensland 4226, Australia
clinicians in providing evidence-based management 
for AECOPD patients. Most prominent among them 
are the Global Initiative for COPD (GOLD), National 
Institute for Clinical Excellence (NICE) clinical guideline 
on management of COPD,[6,7] and the COPD-X Plan 
(specifically for Australia and New Zealand).[8] The 
COPD-X plan provides recommendations to assist 
clinicians in confirming the exacerbation and categorizing 
severity (spirometry, blood gas measurements, chest 
X-ray, and electrocardiography) and optimizing treatment 
(bronchodilators, glucocorticoids, antibiotics, controlled 
oxygen therapy, and ventilatory assistance).[9] Adherence 
to guideline-based management of AECOPD is not only 
expected to achieve good outcomes for the immediate 
treatment of the exacerbation, but also long-term outcomes 
such as lung function, morbidity, and mortality. [3] To 
date there have only been a few ED validation studies 
of the COPD management guidelines.[10-12] To the best 
of our knowledge there has been only one Australian 
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a 
major cause of morbidity and mortality both in Australia[1] 
and worldwide.[2] It is estimated that about 2.1 million 
Australians suffer from COPD.[1] The clinical course of 
COPD is aggravated by exacerbations, characterized by 
increased cough, dyspnea, and production of purulent 
sputum.[3] Patients with an acute exacerbation of COPD 
(AECOPD) often present to the emergency department 
(ED) and many subsequently require hospitalization 
for ongoing management. In 2008-2009, COPD-related 
hospitalization accounted for 56,201 hospital admissions 
for Australians aged 55 years and over.[4] In this context, 
it is estimated that COPD is the second leading cause of 
avoidable hospital admissions in Australia.[5]
Clinical guidelines have been developed and widely 
promoted to assist ED and hospital and community 
Background: Currently there is a paucity of information about biomarkers that can predict hospitalization for acute exacerbations 
of chronic obstructive pulmonary disease (AECOPD) patients presenting to the emergency department (ED). There is limited data 
on the consistency of ED management of AECOPD with local COPD guidelines. The aim of this study was to identify biomarkers 
associated with hospitalization in AECOPD patients and to determine if the ED management was concordant with local COPD 
guidelines. Materials and Methods: We performed a retrospective audit of consecutive AECOPD patients presenting to the Gold 
Coast Hospital ED over a 6-month period. Results: During the study period, 122 AECOPD patients (51% male, mean age (SE) 
71 (±11) years) presented to the ED. Ninety-eight (80%) patients were hospitalized. Univariate analysis identified certain factors 
associated with hospitalization: Older age, former smokers, home oxygen therapy, weekday presentation, SpO2 < 92%, and raised 
inflammatory markers (white cell count (WCC) and C-reactive protein (CRP)). After adjustment for multiple variable, increased age 
was significantly associated with hospitalization (odds ratio (OR) 1.09; 95% confidence interval (CI): 1.00-1.18; P = 0.05). Radiology 
assessment and pharmacological management was in accordance with COPD guidelines. However, spirometry was performed in 
17% of patients and 28% of patients with hypercapneic respiratory failure received noninvasive ventilation (NIV). Conclusion: We 
identified several factors on univariate analysis that were associated with hospitalization. Further research is required to determine 
the utility of these biomarkers in clinical practice. Also, while overall adherence to local COPD guidelines was good, there is scope 
for improvement in performing spirometry and provision of NIV to eligible patients.
Key words: Emergencies, lung disease, obstructive
Address for correspondence: Dr. Krishna Bajee Sriram, Department of Respiratory Medicine, Gold Coast University Hospital, 1 Hospital Boulevard, 
Southport, QLD-4215, Australia. E-mail: bajeekrishna@gmail.com
Received: 01-08-2013; Revised: 17-01-2014; Accepted: 29-01-2014
O
r
ig
in
a
l
 a
r
t
ic
l
e
How to cite this article: Khialani B, Sivakumaran P, Keijzers G, Sriram KB. Emergency department management of acute exacerbations of chronic 
obstructive pulmonary disease and factors associated with hospitalization. J Res Med Sci 2014;19:297-303.
Khialani, et al.: AECOPD in the emergency department
Journal of Research in Medical Sciences| April 2014 | 298
study, which was a retrospective audit performed across 
five Melbourne EDs.[10] However, the study only measured 
compliance with evidence-based recommendations 
regarding use of bronchodilators, methylxanthines, steroids, 
and noninvasive ventilation (NIV).[10] More recent studies on 
the actual standards of clinical care provided to AECOPD 
patients in the ED are lacking.
The current study examined the characteristics, assessment, 
management, and outcome of AECOPD presentations to 
a large regional Australian hospital ED. The objective of 
the study was to determine the factors associated with 
hospitalization and to examine compliance with the 
COPD-X Plan 2011[9] recommendations (most current 
version at the time of the study) for assessment and 
management of AECOPD patients.
MATERIALS AND METHODS
A retrospective cohort study was conducted at the Gold 
Coast Hospital, Southport Campus. This is a 570-bed major 
regional teaching hospital with all major specialties, except 
for cardiac surgery and burns. The ED of the Gold Coast 
Hospital provides care for a mixed adult and pediatric 
(approximately 70 and 30%, respectively) population. In 
2012, there were more than 67,000 presentations to the 
Gold Coast Hospital ED. Included in the study were adult 
patients (age ≥ 18 years) diagnosed with COPD by a medical 
practitioner, who had presented to the ED over a 6-month 
period (December 15, 2011-June 15, 2012). COPD patients 
whose primary reason for admission was not due to an 
acute exacerbation were excluded from the study. When 
patients presented with AECOPD more than once in the 
study period, only the first presentation was used for the 
primary analysis. The Gold Coast Health Services District 
Human Research Ethics Committee approved the study 
(Ethics Reference Number: HREC/12/QGC/99).
Potential study subjects were identified on the basis of 
International Classification of Diseases (ICD)-10 codes 
of E65A and E65B (complex and noncomplex COPD). 
Eligible patients’ electronic medical record (EMR) entries, 
ED information system (EDIS) records, and electronic 
discharge summaries were reviewed. Biochemistry results 
were obtained through the AUSLAB laboratory information 
system. The following information was collected: 
• Patient demographics (age, gender, smoking status, 
living situation, and comorbidities)
• Characteristics of underlying disease (oxygen therapy 
at home and COPD-related hospital admissions in the 
preceding 12 months)
• Features of current exacerbation (day of week of 
presentation, clinical symptoms on presentation, and 
vital signs)
• Investigations performed in ED (spirometry, chest X-ray, 
full blood counts, biochemistry, and blood gas analysis)
• Treatments provided in ED (oxygen, systemic steroids, 
antibiotics, and bronchodilators)
• Outcomes (admission or discharge from ED)
• Follow-up: COPD-related ED presentations over the 
subsequent 3 months.
According to the COPD-X Plan, NIV is indicated for severe 
dyspnea that responds inadequately to initial emergency 
therapy, confusion, lethargy or evidence of hypoventilation, 
persistent or worsening hypoxemia despite supplemental 
oxygen, worsening hypercapnia (PaCO2 > 70 mmHg), or 
severe or worsening respiratory acidosis (blood pH < 7.3). 
However, the strongest indication for NIV in AECOPD 
patients is for acute hypercapnic respiratory failure 
(arterial blood pH of less than 7.35 and PaCO2 >45 mmHg). 
Adherence to the COPD-X Plan regarding the evaluation 
and treatment of AECOPD was assessed.[9]
Statistical analysis
All statistical analyses were performed using Statistical 
Package for Social Sciences (SPSS) version 20.0 (SPSS, 
Chicago, IL, USA). Kolmogorov-Smirnov and Shapiro-
Wilk tests were used to assess for normality of the data. 
Normally distributed data was analyzed for differences 
between individual groups using the Student’s t-test and 
presented as mean and standard error. Nonparametric data 
was analyzed for differences between groups using the 
Mann-Whitney U test and results expressed as median and 
interquartile range. Logistic regression analysis was used to 
identify factors associated with hospitalization. Variables 
from the univariate analysis that which had P-values < 0.05 
were evaluated for the multivariate logistic regression 
analysis. Statistical significance was indicated by P-value 
of less than 0.05.
RESULTS
During the 6-month study period, 188 patients were 
identified using the ICD-10 codes. After review of the 
medical case records, 12 presentations were excluded from 
analysis as they were found to be either incorrectly coded 
or AECOPD was not the primary reason for presentation to 
the ED. Final analysis was performed on 122 patients who 
had 176 AECOPD presentations. Baseline characteristics and 
information about the ED presentation and management are 
summarized in Table 1. Mean age (± standard error (SE)) of 
the patients was 71 (±11) years and 51% were male. Twenty-
eight percent of patients were living alone and 23% were 
current smokers. One-third of patients used home oxygen 
therapy and almost 40% of patients had been hospitalized 
for AECOPD in the preceding 12 months.
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Eighty percent of AECOPD patients who presented to the 
ED were hospitalized. Admitted patients in comparison to 
discharged patients, were older (75 vs 65 years, P = 0.005), 
received home oxygen (39 vs 13%, P = 0.016), presented 
on a weekday (62 vs 37%, P = 0.038), had lower oxygen 
saturations (median SpO2, 92 vs 94%, P = 0.034), and had a 
higher median white cell count (WCC; ×109/L) (10.5 vs 9.2, 
P = 0.046) and C-reactive protein (CRP; 20 vs 8.65 mg/L, 
P = 0.032). AECOPD patients who were eventually 
hospitalized received supplemental oxygen (82 vs 42%, 
Table 1: Demographic and baseline clinical characteristics of patients presenting to the emergency department 
according to hospitalization status
Characteristics Admitted (N = 98) Not admitted (N = 24) P-value
Age in years, median (IQR) 75 (51-89) 63 (43-91) <0.001
Female gender 49 (50) 11 (45.8) 0.82
Social situation
Lives alone 24 (24.5) 10 (41.7) 0.13
Lives with family/supportive accommodation 71 (72.4) 13 (54.2)
Unknown 3 (3.1) 1 (4.2)
Smoking status
Current smoker 17 (17.3) 11 (45.8) <0.001
Former smoker 81 (82.7) 13 (54.2)
Pack-year of smoking, median (IQR) 50 (5-140) 45 (20-150) 0.56
>1 COPD hospitalization in the previous 12 months 43 (43.9) 6 (25) 0.11
Uses oxygen at home 38 (38.8) 3 (12.5) 0.02
Comorbidity
Coronary artery disease 32 (32.7) 8 (33.3) 1.00
Congestive heart failure 16 (16.3) 6 (25) 0.38
Depression 24 (24.5) 4 (16.7) 0.59
History of arrhythmia 17 (17.3) 3 (12.5) 0.76
Weekend presentation 37 (37.8) 15 (62.5) 0.04
ED presentation
Brought to ED by ambulance 53 (54.1) 9 (37.5) 0.16
Failure to respond to initial medical management 73 (74.5) 13 (54.2) 0.08
Increasing dyspnea 96 (98) 24 (100) 1.00
Increasing cough 70 (71.4) 16 (66.7) 0.63
Increasing sputum 58 (59.2) 11 (45.8) 0.26
Change in sputum color 46 (46.9) 9 (37.5) 0.50
Symptoms present for more than 3 days 48 (49) 13 (54.2) 0.83
New arrhythmia 2 (2.0) 1 (4.2) 0.49
Median respiratory rate, breaths/min (IQR) 24 (16-48) 23 (14-36) 0.38
Median SpO2 on presentation to ED (IQR) 92 (66-100) 94 (83-99) 0.03
Investigations in ED
Unilateral infiltrate/consolidation on CXR 46 (46.9) 7 (29.2) 0.17
Blood gas analysis-ABG 30 (30.6) 4 (16.7) 0.21
Blood gas analysis-VBG 38 (38.8) 6 (25) 0.24
Median WBC (×109/L) (IQR) 10.5 (2.9-33.9) 9.2 (5.2-16.6) 0.04
Median CRP (mg/L) (IQR) 20 (2-320) 8.65 (3-247) 0.03
Blood gas, median (IQR)
pH 7.37 (7.07-7.47) 7.38 (7.28-7.43) 0.79
PaO2 in mmHg* 65 (44-344) 75 (67-79) 0.35
PaCO2 in mm Hg 52 (31-109) 46.5 (32-84) 0.57
Spiromerty in ED or hospital 19 (19.4) 2 (8.3)
ED course
Received supplemental oxygen in ED 80 (81.6) 10 (41.7) <0.001
Received antibiotics in ED 66 (67.3) 12 (50) 0.15
Received systemic corticosteroid treatment in ED 79 (80.6) 17 (70.8) 0.46
Received NIV in ED 10 (10.2) 1 (4.2) 0.69
Received inhaled bronchodilators in ED 87 (88.8) 20 (83.3) 0.49
COPD-related presentation to ED within 3 months 36 (36.7) 7 (29.2) 0.63
*pH and PaCO2 were available in 48 (39%) patients only. CXR = Chest X-ray; NIV = Noninvasive ventilation; IQR = Interquartile range; COPD = Chronic obstructive pulmonary 
disease; ED = Emergency department; ABG = Arterial blood gas; VBG = Venous blood gas; WBC = White blood cell; CRP = C-reactive protein
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P < 0.001) and systemic corticosteroids (81 vs 71%, P = 
0.046), more often compared to AECOPD patients who were 
discharged from the ED. Overall, 34% (n = 43) of patients 
represented within the study period with another episode 
of AECOPD, but this proportion of representations was 
the same between the hospitalized patients compared to 
patients who were discharged from the ED (representation 
rate: 37 vs 29%, P = 0.635). Multivariate analysis was 
performed on the predictors of admission [Table 2]. Among 
the variables, only increased age was independently 
associated with hospitalization (odds ratio (OR) 1.09; 95% 
confidence interval (CI): 1.00-1.18; P = 0.05).
Overall, adherence to the COPD-X Plan guideline was 
good [Table 3]. Adherence to guideline recommendations 
regarding chest radiographs was excellent (100%). Most 
patients received bronchodilators (88%) and systemic 
corticosteroids (79%), but only 67% of patients with 
appropriate indications, received antibiotics. There was 
also good adherence to the guideline recommendations 
for hospitalization. The majority of patients with marked 
increase in intensity of symptoms or those who had failed 
to improve with ambulatory treatment (75%) and had 
worsening hypoxia (88%) were hospitalized. However, 
adherence to certain guideline recommendations was 
suboptimal: Objective measurement of pulmonary function, 
while in the ED was obtained in only 17% of patients and 
evaluation of arterial blood gases was performed in only 
28% overall. However, when only patients with a severe 
exacerbation (SpO2 < 92%) are considered, an arterial (ABG) 
or venous blood gas (VBG) analysis was performed in 77% 
of patients.
Using an arterial blood pH of less than 7.35 as the cutoff 
value, there were 39 admissions where treatment via NIV 
was indicated. The median (interquartile range (IQR)) PaCO2 
for these 39 admissions was 59 (48-102) mmHg. Despite 
suitable NIV equipment being available, this treatment was 
provided for only 11 (29%) patients. Interestingly there was 
no documentation as to reasons why NIV was not provided 
to the 71% (n = 28) of patients with type 2 respiratory failure.
DISCUSSION
Our study evaluated the ED management in patients 
with an AECOPD over a 6-month period in a regional 
tertiary hospital. Eighty percent of these patients were 
hospitalized. Overall there was good adherence to 
many of the recommendations of the COPD-X Plan. 
However, there are certain clinical management areas 
with potential for improvement. We identified several 
factors in AECOPD patients that were associated 
with hospitalization. This may facilitate future ED 
management of AECOPD patients.
In our study, 80% of COPD patients presenting to ED were 
hospitalized, which is similar to previous reports.[10,13] 
A better understanding of the factors associated with 
hospitalization may translate to more rapid decision making 
for ‘at risk’ patients, resulting in less time spent in the ED and 
better clinical outcomes. This is of particular interest with 
the introduction of the National Emergency Access Target 
(NEAT) to address growing ED demand (http://www.health.
gov.au and http://www.ecinsw.com.au/neat). However, 
currently there are no reliable methods of risk stratification 
for patients with COPD exacerbations presenting to the ED. 
Recently, Garcia-Sanz et al.,[14] evaluated 409 exacerbations 
in 239 COPD patients over a 12-month period and found 
that impaired oxygenation, presence of neutrophilia, and 
administration of antibiotics in ED were associated with 
hospitalization. Interestingly, impaired oxygenation and 
neutrophilia were associated with hospitalization in our 
study as well. We also found that an elevated CRP was also 
associated with hospital admission. CRP is an inflammatory 
biomarker that has been previously been associated with 
severe COPD.[15,16] Furthermore, in COPD exacerbations, 
raised CRP has been associated with bacterial infections[17] 
and adverse clinical outcomes.[18] Hence it is not surprising 
that a raised CRP is a biomarker for severe AECOPD 
exacerbations that require hospital admissions. We found 
that hospital admission occurred more frequently during 
weekdays compared with weekends, potentially due to 
patients postponing presentation till after the weekend or 
review by own general practitioner (GP). Our results are 
consistent with those of a recent large multicenter study of 
nine EDs, which reported that a weekday presentation was 
associated with longer length of stay in ED and increased 
likelihood of hospitalization.[19]
Interestingly, we found that while the alterations in the 
individual variables were associated with admission, 
only increased age was significantly associated with 
hospitalization. Other variables did not achieve statistical 
significance. This is most likely due to the relatively small 
sample size in our study. The clinical utility of ED physicians 
being aware of these admission associated factors in 
Table 2: Odds ratio by binary logistic regression for 
hospitalization
Variables OR (95% CI) P-value
Age 1.09 (1.00-1.18) 0.05
Smoking status 1.05 (0.34-3.23) 0.93
Home oxygen 1.73 (0.26-11.34) 0.57
Weekend presentation 1.57 (0.30-8.31) 0.59
Presenting SpO2 1.03 (0.92-1.16) 0.62
WBC (×109/L) 1.12 (0.91-1.38) 0.28
CRP (mg/L) 1.00 (0.99-1.01) 0.84
Supplemental oxygen in ED 1.60 (0.27-9.56) 0.61
CI = Confidence interval; OR = Odds ratio; ED = Emergency department; 
CRP = C-reactive protein; WBC = White blood cell
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improving outcomes for AECOPD patients will need to be 
evaluated in multicenter prospective studies. If validated, 
then the factors may need to be incorporated into future 
versions of AECOPD guidelines.
In this study, we found generally good concordance 
of ED management with guideline recommendations, 
such as the testable indicators for hospitalization in the 
COPD-X Plan. Not unexpectedly we found that older 
age and home oxygen therapy were associated with 
hospitalization. These two factors, while not present in the 
COPD-X Plan, are recommended in international COPD 
guidelines.[6,7] With regards to treatment given in the ED, 
bronchodilators, systemic corticosteroids, and antibiotics 
were provided in the great majority of patients. These 
results are consistent with a previous study of Australian 
EDs, with our study having a higher prescription rate 
of systemic corticosteroids (79 vs 57%).[10] The higher 
adherence to guideline recommendations in our study 
maybe explained in part by the different time periods of 
the two studies (2011-2012 vs 2006-2007[10]). The trend for 
increased prescription of systemic steroids more recently 
is consistent with the findings of Tsai et al., who noted 
that between 2000 and 2005-2006, there was an increased 
prescriptions of systemic corticosteroids and antibiotics 
in a Boston ED.[13] This finding may be due to increased 
awareness of guideline recommendations among ED 
physicians.
As per the COPD-X guidelines, the appropriate management 
of hypercapneic respiratory failure begins with the 
performance of an arterial blood gas (ABG) when the 
Table 3: Observed frequencies for diagnostic procedures and clinical management of AECOPD patients in the ED
Category COPD-X guideline recommendation Our study (%) Comment
Confirm exacerbation 
and categorize severity
‘Assessment of severity of the exacerbation 
includes…spirometry’
17.2 Patients who underwent spirometry either in 
ED or in the ward following hospitalization
‘Assessment of severity of the exacerbation 
includes…in severe cases (FEV1 < 40%
predicted), blood gas measurements’
77.11 Includes ABG and VBG
SpO2 < 92% was used as a surrogate marker 
for severity of AECOPD
SpO2 < 92% in 48 patients
‘Assessment of severity of the exacerbation 
includes…chest X-rays’
100
Optimize treatment ‘Inhaled bronchodilators are effective treatments 
for acute exacerbations’
87.7
‘Systemic glucocorticoids reduce the severity of 
and shorten recovery from acute exacerbations’
78.7
‘Exacerbations with clinical signs of infection 
(increased volume and change in color of 
sputum and/or fever, leukocytosis) benefit from 
antibiotic therapy’
66.7 54 patients had increased sputum volume and 
reported change in sputum color and 36 of 
this subgroup received antibiotics
‘Controlled oxygen delivery (28% or 0.5-2.0 L/
min) is indicated for hypoxemia’
73.8 All patients who received supplemental oxygen 
therapy in ED
‘Noninvasive positive pressure ventilation is 
effective for acute hypercapnic ventilatory failure’
28.6 28 patients had type 2 respiratory failure and 
NIV was provided to 8 patients
Indications for 
hospitalization of 
patients with chronic 
obstructive pulmonary 
disease
Marked increase in intensity of symptoms Worsening 
dyspnea—98%
Worsening cough 
71.4%
Increased sputum 
production—59.2%
Patient has acute exacerbation…plus…
Inadequate response to ambulatory management
74.5 Patients had presented to ED because there 
was no improvement with escalated COPD 
therapy as per their GP or COPD action plan
Worsening hypoxemia or cor pulmonale 87.5 Patients with SpO2 < 92%
High risk comorbidity condition-pulmonary (e.g., 
pneumonia) or nonpulmonary
46.9 Patients with unilateral infiltrates or 
consolidation
Newly occurring arrhythmia 2
Inability to walk between rooms when previously 
mobile
NA Not testable in our study
Inability to eat or sleep because of dyspnea NA Not testable in our study
Cannot manage at home even with home-care 
resources
NA Not testable in our study
Altered mental status suggestive of hypercapnia NA Not testable in our study
AECOPD = Acute exacerbations of chronic obstructive pulmonary disease; ED = Emergency department; ABG = Arterial blood gas; VBG = Venous blood gas; WBC = White blood 
cell; CRP = C-reactive protein; GP = General practitioner; NA = Not applicable; FEV1 = Forced expiratory volume in 1 s
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forced expiratory volume in 1 s (FEV1) is less than 1.0 L 
or less than 40% of predicted or if there are any signs of 
respiratory failure or cor pulmonale.[9] Overall we found 
that an ABG was performed in 28% of patients, but that 
a blood gas analysis (ABG and/or VBG) was performed 
in hypoxic patients in 77% of patients. In our experience, 
the decision to perform a blood gas analysis is based on 
baseline oxygen saturations and clinical acumen rather 
than spirometric values. In our study, a sizeable proportion 
of patients had a VBG instead of an ABG. The practice 
of measuring VBG in AECOPD patients is supported by 
recent studies, which have shown that a VBG in conjunction 
with oxygen saturation has similar clinical utility to an 
ABG in identifying hypercapneic respiratory failure.[20-22] 
So, we found that even though spirometry in ED was not 
performed commonly, the decision to perform (arterial 
or venous) blood gas analysis was based on appropriate 
clinical judgment.
The benefits of NIV in the treatment of hypercapneic 
respiratory failure in AECOPD include improved survival, 
reduced length of stay, and need for intubation. [23] 
However in our study NIV was provided to only 29% of 
eligible patients. Interestingly, very similar results have 
been reported in other national and international COPD 
audits.[24-27] Previous studies have also noted that often no 
reason is provided in the medical notes as to why NIV is 
not provided to eligible patients. Possible explanations for 
such low provision of NIV in eligible patients include a poor 
understanding of the clinical indications for NIV, limited 
experience and/or lack of staff education.[26] Educational 
initiatives including checklists have been shown to improve 
adherence to guidelines in the provision of NIV for eligible 
patients.[28] Further study is required to understand 
why NIV provision is low in ED (both in Australia and 
worldwide) and measures that need to be undertaken to 
improve this practice.
We found that spirometry had been performed in the ED 
in only 17% of patients. This is particularly divergent from 
the COPD-X Plan which recommends that spirometry can 
be performed even in the sickest of patients, unless they are 
confused or comatose.[9] It has been suggested that increased 
rates of spirometry either at presentation or at some stage 
during the admission could be expected to allow better 
characterization of disease severity, and hence improved 
management.[26] However, the feasibility and accuracy of 
spirometry in the ED has been questioned in the GOLD 
guidelines[29] and it has been noted that it is rarely performed 
in the ED.[11] An alternative to consider for future studies will 
be to obtain an accurate assessment of smoking history, and 
to use this information as a proxy measure of spirometry 
since pack-years of smoking is a surrogate measure of the 
severity of COPD.[11,30]
We acknowledge that our study design and results have 
several limitations. First, because our study is a retrospective 
review of medical records it suffers from the principal 
assumption that documentation is an accurate reflection 
of clinical practice. Second, it is possible that by using ICD 
codes as a strategy of identifying COPD patients for our 
study, we may have missed patients due to the problems 
of underreporting, incorrect EDIS diagnosis, and/or ICD 
coding. We identified 176 ED presentations in 6 months 
which equates to approximately 7.6 per 1,000 presentations, 
which is similar to reports in the US where COPD accounts 
for 10 per 1,000 ED presentations.[31] Third, since we did not 
interview ED physicians, we cannot determine if there were 
individual physician factors that may have been associated 
with hospitalization. Fourth, potentially important 
measurements were not obtained in all patients, particularly 
spirometry and blood gas analysis. However, since our study 
was designed to study actual ‘real-world’ ED practice, we do 
not consider this to be a study-related problem.
CONCLUSION
We also identified several factors that are associated with 
hospital admission. Awareness of these factors in the design 
of future AECOPD management guidelines may allow ED 
physicians to triage patients who are likely to be admitted 
rapidly and efficiently. We also found that in general, ED 
clinicians adhered well to the COPD-X Plan for management 
of AECOPD patients. However there is scope for improvement 
in the performance of spirometry and provision of NIV to be 
more in concordance with national COPD guidelines.
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